AKTIS ONCOLOGY INC (AKTS) Stock Technical Analysis
NASDAQ:AKTS • US01021M1045
Taking everything into account, AKTS scores 3 out of 10 in our technical rating. AKTS performed below average in the overall market. Although the medium term picture in unclear, the short term picture is clearly negative.
- When comparing the yearly performance of all stocks, AKTS is a bad performer in the overall market: 100% of all stocks are doing better.
- AKTS is part of the Biotechnology industry. There are 520 other stocks in this industry, of which 93% are performing better than AKTS.
- Both the short term and long term trends are positive. This is a very positive sign.
- In the last month AKTS has a been trading in the 16.80 - 22.85 range, which is quite wide. It is currently trading in the middle of this range, so some resistance may be found above.
AKTS has a bad technical rating, but it does show a decent setup pattern. We see reduced volatility while prices have been consolidating in the most recent period. There is very little resistance above the current price.
More info and screens
17.45
We found 1 important support area.
- A support zone ranging from 17.63 to 17.76. This zone is formed by a combination of multiple trend lines in multiple time frames.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | UP | POSITIVE | The long term trend for AKTS is up. |
| ChartMill Short Term Trend Indicator | UP | POSITIVE | The short term trend for AKTS is up. |
| ChartMill Relative Strength | 0 | NEGATIVE | AKTS has a low relative strength, it was outperformed by 100% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | NEGATIVE | The current price of AKTS is below a declining SMA(20). |
| Relative Strength Index/RSI (14) | 44.76 | NEUTRAL | The RSI value for AKTS is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | -0.78 | NEGATIVE | The MACD value suggests AKTS has a negative trend, although the MACD value is rising. |
| Stochastics (14,3) | 25.01 | NEUTRAL | The Stochastics value for AKTS is a neutral value. |
| Average True Range in percent/ATR (20) | 8.49 | HIGH VOLATILITY | The high ATR as a percentage value for AKTS suggests high volalility. |
| Average Directional Index/ADX (14) | 20.73 | NEUTRAL | The ADX value for AKTS suggests a possible start of a new trend. |
18.9
+0.49 (+2.66%)
AKTIS ONCOLOGY INC / AKTS FAQ
What is the ChartMill technical rating of AKTIS ONCOLOGY INC (AKTS) stock?
ChartMill assigns a technical rating of 3 / 10 to AKTS.
What is the trend direction for AKTS stock?
The current trend direction for AKTIS ONCOLOGY INC (AKTS) is Bullish.
What is the RSI signal for AKTIS ONCOLOGY INC (AKTS) stock?
AKTIS ONCOLOGY INC (AKTS) has an RSI value of 44.7607. This indicates that the stock is currently neutral.
What is the short term momentum for AKTIS ONCOLOGY INC (AKTS) stock?
The short term momentum for AKTIS ONCOLOGY INC (AKTS) is positive.
What is the buy/sell signal for AKTS stock?
The buy/sell signal for AKTIS ONCOLOGY INC (AKTS) is buy as both the short term and long term trends are positive.